The generation of met~stases by n~oplastic cells constitutes the mam problem m tumor malignancy. Metastasis is a mult~step pr~ cess in which each of the sequentIal steps IS controlled by different properties of the disseminating tumor cells. The host's capacity to recognize metastatic, as against nonmetastatic, cells of the tumor cell population could exert a controlling effect on each of the stages culminating in the progressive growth of metastases. Recognition of cel!-surface antigenic epitopes on metastatIc cells via T lymphocytes would be restricted by cell-surface class I glycoproteins coded by the major histocompatibility c?mplex (MHC). In mice, such glycoprotems are coded by the H-2D and H-2K genes of the MHC, and differences in their expression on metastatic, as distinct from nonmetastatic, cells of a given tumor could therefore elicit different T cell effector responses, which would then determine the fate of the disseminating tumor cells. The feasibility of an MHC control of the metastatic process attracted us during investigations of the unique properties of a metastatic carcinoma originated in a C57BL (H -2~ mouse, the 3LL Lewis lung carcinoma. Fo~ lowing transplantation in syngeneic ammals, the 3LL carcinoma generates spontaneous lung metastases while growing locally at any site of transplantation. Ho~ ever this tumor differs from all normal tIs-, . .
A. Introduction
The generation of met~stases by n~oplastic cells constitutes the mam problem m tumor malignancy. Metastasis is a mult~step pr~ cess in which each of the sequentIal steps IS controlled by different properties of the disseminating tumor cells. The host's capacity to recognize metastatic, as against nonmetastatic, cells of the tumor cell population could exert a controlling effect on each of the stages culminating in the progressive growth of metastases. Recognition of cel!-surface antigenic epitopes on metastatIc cells via T lymphocytes would be restricted by cell-surface class I glycoproteins coded by the major histocompatibility c?mplex (MHC). In mice, such glycoprotems are coded by the H-2D and H-2K genes of the MHC, and differences in their expression on metastatic, as distinct from nonmetastatic, cells of a given tumor could therefore elicit different T cell effector responses, which would then determine the fate of the disseminating tumor cells. The feasibility of an MHC control of the metastatic process attracted us during investigations of the unique properties of a metastatic carcinoma originated in a C57BL (H -2~ mouse, the 3LL Lewis lung carcinoma. Fo~ lowing transplantation in syngeneic ammals, the 3LL carcinoma generates spontaneous lung metastases while growing locally at any site of transplantation. Ho~ ever this tumor differs from all normal tIs-, . .
sues and from many other tumors III Its ca-
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Institute of Science, Rehovot 76100, Israel pacity to grow in allogeneic recipients. Yet, metastases were generated only when the tumor grew in syngeneic animals [1] . The allograft response elicited by the local tumor could not arrest the local growth, but was sufficiently powerful to prevent the growth of metastatic lung nodules. Subsequent experiments indicated that the spontaneous lung metastases behaved as "secondary" grafts, being rejected by.the alloreactive T cells that had been ehclted by the local graft [2] . When the .3~L cells were injected intravenously to sImIlar allogeneic mice, lung tumors ~eveloped as "primary" grafts and these dId grow. progressively [2] . Our approach to the question as to whether differences in the expression of H-2Db ver- were incubated at 4°C for 30 min in purified anti-K b (28-13-3) monoclonal antibody or anti-D b (28-14-8) antibody, washed twice in phosphate-buffered saline with 1 % bovine serum albumin and 0.2% sodium azide, and reincubated in fluorescein isothiocyanate-1abeled rabbit anti-mouse Ig. Fluorescence-activated cell sorter II analysis was performed with photomultiplier tube set at 550 V b In 10 C57BL/6J male mice, 10 5 cells were inoculated i.f.p. When the primary tumors reached 8 mm in diameter tumor-bearing legs were amputated. Metastatic load was determined 30 days after amputation SUS H-2Kb glycoproteins (the class I antigens of the mouse MHC) control the metastatic potency of 3LL cells was triggered by earlier experiments in our laboratory. In these we aimed at determining the minimum genetic identities between the tumor strain of origin and the host's phenotype that are required for the generation of me-500 tastases. We found that identities at the H -2Db gene and the non-MHC background are sufficient for metastasis formation, whereas the H-2K phenotype of the recipient was completely irrelevant [1] . It then turned out that identity at the H-2Kb was unnecessary, because the 3LL tumor hardly expressed the H-2Kb on its cell surface [3] . Treatment was performed with 10 5 tissue culture-propagated cells transferred to 100-mm petri dishes in 10 ml Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS), 1 % glutamine, 1 % sodium pyruvate, 1 % nonessential amino acids, and 1 % antibiotics in the presence of 100 units/ml interferon (a and p, 10 7 units/mg) or 10--6 mol/liter retinoic acid. The cells were grown to confluency (1 week), with twice-weekly changes of growth medium a Direct radioimmunoassay: 10 6 living cells were incubated with 50 III 125I-Iabeled antibody, 0.1-1.5 Ilg protein A-Sepharose-purified (28-14-8 and 20-8-4), or 0.5-7.5 Ilg semipurified antibody (28-13-3). Binding was done for 1 h at 4°C in a 300-lll final volume of phosphate-buffered saline (PBS), 5% FCS, after which plates (24 wells) were washed four times in PBS-FCS and cells were collected into tubes and monitored in a gamma counter. The saturation values of a dose-dependence curve are given
The question which thus arose was whether the absence of H-2Kb expression concomitant with the presence of H-2Db determined the metastatic potency of the tumor cell population. To answer this question we cloned 3LL cells in soft agar and tested the metastatic potency of individual clones. We found that the clones differ in their capacity to generate spontaneous lung metastases when grown intrafootpad (i.f.p.) in syngeneic animals. As previously demonstrated for other tumors [4] , this tumor cell population varied in the metastatic potency of its individual cells. To test whether there is a correlation between the metastatic properties of individual clones and the expression of MHC genes, we used monoclonal antibodies 28-13-3 and 20-8-4, which identify H-2Kb molecules, and antibody 28-14-8, which identifies H-2Db molecules [5] . We analyzed 30 clones by direct radioimmunoassay and with the fluorescence-activated cell sorter. We found (Table 1) that the lower the H-2K b l H-2Db ratio, the higher was the metastatic potential o/the cloned cells [6] .
C. Induced Alterations of H-2K/H-2D
Ratio Alters the Metastatic Phenotype
To examine whether the relative expression of class I antigens of the MHC was causally related to its metastatic phenotype, we attempted to alter the H-2K b /H-2D b ratio, and then to test whether such alteration will change the metastatic potency of the cells. For this purpose we treated in vitrocloned tumor cells with either interferon a+f3 (a stimulator ofH-2 synthesis) or with retinoic acid. Cells of two clones were used in these experiments: The low metastatic A9 clone that expresses both the H-2K and the H-2D glycoproteins, and the highmetastatic DI22 clone that expresses the H-2Db molecules but lacks H-2Kb expression. It was found that interferon caused an increase in both K and D expression of both A9 and DI22 cells, yet the net increase in H-2Db expression was significantly higher than that of H-2Kb expression, thus lowering the H-2K/H-2D ratio (Table 2 ). These changes were associated with a significant increase in the metastatic load produced by both the A9 clone and the DI22 clone. Treatment with retinoic acid did not affect H-2K expression, but increased significantly H-2Db production, lowering the H-2K/H-2D ratio even further. This again increased the metastatic load produced by Dl22 cells, and converted the low metastatic A9 clone to a high metastatic phenotype ( of the cell surface expression of H-2Db and, especially, of H-2Kl5 molecules on A9 and DI22 tumor cells (Fig. 1) . While testing for spontaneous lung metastases we observed no changes in the low metastatic phenotype of A9 clone and a reduction in the number of metastatic nodules formed by the high metastatic DI22 clone.
D. The Relative Expression of H-2K/H-2D Molecules is Correlated with the Immunogenic Properties of the Cloned Cell Populations
We then considered whether the low H-2K/H-2D ratio determines a metastatic phenotype because it confers a low immunogenic potency on the neoplastic cells.
I. Growth and Metastasis in Allogeneic Recipients
As stated above, the parental3LL cell population, manifesting a low H-2K/H-2D ratio, can grow across H-2 barriers although metastases are not formed in allogeneic mice. We also tested whether the nonmetastatic A9 clone (K+D+) and the DI22 clone (K-D+) differed in their capacity to grow in allogeneic recipients. Whereas the DI22 grew locally without generating metastases in BALB/c (H-2
d ) and C3H (H-2~
mice, the nonmetastatic A9 clone was rejected by allogeneic recipients [7] . The metastatic potential in syngeneic mice was thus correlated with the immunogenic effect determining growth in allogeneic mice.
II. Growth and Metastasis in Congenic Recipients
Clone A9 behaves as a regular incompatible immunogenic allograft in allogeneic mice. To test whether the class I antigens alone on the A9 clone could elicit rejection of the grafted tumor, 10 5 A9 or Dl22 cells were inoculated to groups of H-2-recombinant mice on a C57BL/1O background [7] . We used BlO.HTG (KdD b ), BlO.D2 (KdDd), and BlO.A(4R) (KkDb) mice. Clone A9 (KbDb) grew in 9110 B 1O.HTG mice at a slower rate than in C57BL/6J mice. Only partial and slow growth was observed in BIO.D2 mice (51 11), and the A9 clone grew in only one of nine mice of the BlO.A(4R) strain. In contrast, Dl22 grew in C57BL/6J and in the three recombinant strains at a similar rate. Testing for metastases, we found that DI22 metastasized in C57BL/6J (KbDb), BlO.HTG (KdD b ), and BlO.A(4R) (KkDb), but not in BIO.D2 (KdDd) mice. The Kb_ positive A9 cells grew partially in recombinant mice, while D 122 grew progressively and metastases were rejected only in BIO.D2 (D d ) mice. Thus, the higher immunogenic effect of clone A9, compared with the DI22 clone, is a function of an immune response elicited by the H-2K determinant.
III. Clone A9, Unlike Clone DI22, is Immunogenic in Syngeneic Mice
In view of the differences in growth pattern of A9 and D 122 clones in allogeneic and H-2-recombinant mice [7] , we asked whether the higher immunogenicity of the A9 clone was also effective in the syngeneic host, and whether this could account for the inability of the A9 clone to metastasize. C57BL/6J mice were immunized by three intraperitoneal injections of 10 7 irradiated A9, D122, or 3LL cells at I-week intervals. Ten days after the last injection, immunized mice and controls were challenged by A9 or DI22 cells. We found that immunization by A9 cells significantly slowed the growth rate of a second A9 tumor but did not affect the growth rate of the metastatic Dl22 tumor. Immunization by clone Dl22 or by 3LL did not retard the growth of a second A9 or DI22 tumor. Similar results were obtained when mice were intradermally immunized with living A9 or DI22 cells.
IV. Cytotoxic Activity of Lymphocytes
Sensitized In Vivo to A9 and Dl22 Tumor Cells 
E. Molecular Nature of MHC Gene Products in 3LL Clones
Low metastatic clones such as A9 were shown to bind anti-H-2Kb and anti-H-2D b antibodies, while high metastatic clones such as D122 bound only H-2Db antibodies (Table 2) . We tested the molecular similarity of the MHC glycoproteins to H-2b Fig.2A-D molecules of C57BL/6J spleens. Immunoprecipitation of 125 1 cell surface-labeled and 35S-methionine-labeled extracts of A9 and D 122 clones showed a strict correlation between synthesis and cell surface expression. In D122 and in the parenta13LL cells, but not in A9, synthesis of Kb molecules was suppressed [6] . The 45K proteins precipitated by anti-H-2 b serum or monoclonal anti-H-2K b (from clone A9) were similar in migration to molecules precipitated from C57BL/6J splenocytes, and a 12K ,B2-microglobulin molecule was coprecipitated. Separation on lentil-lectin Sepharose showed that most of the H-2b-encoded proteins were in their glycosylated form [6] . To obtain a better understanding of the transcriptional level of the K gene suppression in metastatic clones, we used Northern blot hybridization to analyze the mRNA from clones A9, DI22, and 3LL as compared to liver mRNA and RNA extracted from metastatic and nonmetastatic clones of another metastatic tumor, the T10 sarcoma (T1O sarcoma is an Fl (H-2 b XH-2 tumor that expresses only D end products of the MHC). We used four probes: (a) a genomic K b , 5' region probe, H8Pst8 [8] ; (b) a cDNA, H-2~ 3' re}ion probe, pH2IIa [9] ; (c) a cDNA, H-2, 5' region probe, pH2III [9] ; and (d) a human HLA-B9 cDNA probe. All these probes hybridize to both K and D end transcripts. Figure 3 shows that the normal H-2 transcript of 2 kb that is expressed in the liver is also expressed at a high level in clone A9 and in the 3LL line. A lower level of transcription of the 2-kb mRNA is observed in clone D122 and in the TIO sarcoma clones, as both Dl22 and all T10 clones lack expression of K end products. Besides the normal 2-kb transcripts, an abnormal RNA of 5.5-6 kb was observed in all tumor clones [10] . This transcript hybridized to the three 5' region probes but not to the 3' region probe. The origin of this large RNA is not yet known, but it may result from the insertion of a foreign DNA into the H-2K gene of the tumors. In this event the large RNA could represent a transcript contain- ---+1 -X..,..-----t\..---------ii a Fig.4A-C . Expression of c-mye and cjos one genes in 3LL clones. Polyadenylated mRNA was selected on oligo-dT cellulose and electrophoresed on formaldehyde-agarose gels. RNA was then transferred onto nitrocellulose filters which were subsequently hybridized with a 32P-Iabeled nicktranslated c-mye probe, washed, and exposed to x-ray film. The same blot was cleaned of the c-mye probe and rehybridized to a/os probe. 1, mRNA from low metastatic A9 clone; 2, mRNA from high metastatic DI22 clone; 3, mRNA from parental 3LL m)'C line. a Hybridization t%s, blots exposed for I day; b hybridization t%s, blots exposed for 3 days; c hybridization to mye, blots exposed for I day myeloid leukemia line WEHI-3B [11] . Transfection of F9 teratocarcinoma cells by a cloned fos gene was shown by Muller and Wagner to induce differentiation of teratocarcinoma cells to endoderm-like cells [12] . In a recent study of the organization and expression of one genes in metastatic and nonmetastatic clones we observed that the cjos proto-one gene is expressed in the low metastatic clone A9 at high levels, while the high metastatic clone Dl22 does not contain cjos-related m-RNA (Fig. 4) . A low level of c-fos transcription was also observed in parental 3LL cells. Expansion of these results showed that other low metastatic 3LL clones also expressed c-fos. In addition, we found that the c-mye oncogene was amplified 60-fold in all 3LL clones. Thus, the level ofc-mye mRNA is very high in A9 and D122 clones, as well as in the parental 3LL line. Figure 4 demonstrates, using the same Northern blot, that while c-mye is expressed in all three cell types, clos is expressed mainly in the low metastatic A9 clone. Is the expression of fos gene product and a full expression of H-2K and H-2D gene products an indication of a more differentiated state of the A9 low metastatic clone than of the metastatic D 122 clone, and is such a differentiation step crucial in the control of metastatic spread by the host? We are currently investigating these questions.
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